Opiate-Positive Immunoassay Screen in a Pediatric Patient-Reference-Cited by-同舟云学术

Opiate-Positive Immunoassay Screen in a Pediatric Patient

Published:2010-08-01 Issue:8 Volume:56 Page:1220-1223
ISSN:0009-9147
Container-title:Clinical Chemistry
language:en
Short-container-title:

Author:

Straseski Joely A¹,Stolbach Andrew²,Clarke William¹

Affiliation:

1. Department of Pathology and

2. School of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD

Funder

Thermo Fisher Scientific

National Institute of Allergy and Infectious Diseases

National Institute on Drug Abuse

National Institute of Mental Health

NIH

Department of Health and Human Services

Publisher

Oxford University Press (OUP)

Subject

Biochemistry, medical,Clinical Biochemistry

Link

http://academic.oup.com/clinchem/article-pdf/56/8/1220/32654581/clinchem1220.pdf

Reference6 articles.

1. Clinical toxicology;Porter,2006

2. Narcotic withdrawal syndrome caused by naltrexone;Tornabene;Ann Intern Med,1974

3. Toxicologic emergencies;Osterhoudt,2006

4. Opioid antagonists;Howland,2006

5. Naloxone dosage and route of administration for infants and children: addendum to emergency drug doses for infants and children;American Academy of Pediatrics Committee on Drugs;Pediatrics,1990

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo behaviors of meloxicam nanocrystals by intravenous administration are not significantly affected by stabilizers;Journal of Drug Delivery Science and Technology;2023-04

2. ACMT Position Statement: Interpretation of Urine Opiate and Opioid Tests;Journal of Medical Toxicology;2021-11-15

3. Evaluation of optimal urine screening and confirmation cut-off values for opiates, at a national reference laboratory;Turkish Journal of Biochemistry;2021-09-15

4. False Positive Urine Drug Screens in Patients Receiving Oral Naltrexone;Canadian Journal of Addiction;2019-06

5. Newly Emerging Drugs of Abuse;Substance Use Disorders;2019